Overall, SLE-CSQ scores closely correlated with the number of ACR criteria documented in the medical record across the LAUREL (baseline and follow-up) and LFRR cohorts (Spearman r≥0.526 [0.426-0.614 95% CI], p<0.0001, Table 7), as well as ANA titer (Spearman r≥0.238 [0.113-0.367], p=0.0002, Table 7) and number of autoantibody specificities (Spearman r≥0.140 [0.011-0.265], p=0.0286, Table 7). This evidence concerns the gene BTG3 and systemic lupus erythematosus.